Affimed Logo
  • Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • Pipeline and Clinical Trials
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Innately Affimed
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance Affimed
    • Press Release Distribution
  • Careers
    • Culture
  • Contact
Menu

News and Events

See what’s new at Affimed

News

All categories
Earnings
Press Release
All years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Affimed to Present at Noble Financial Capital Markets’ 12th Annual Investor Conference

January 12, 2016

Affimed Added to NASDAQ Biotech Index®

December 14, 2015

Affimed Presents Additional Data on Combination of AFM13 with Checkpoint Inhibitors at ASH

December 6, 2015

Affimed Presents Data Comparing T-­cell-­ and NK-­cell-­ engaging TandAbs AFM11 and AFM12 at ASH

December 6, 2015

Affimed Announces Appointment of Andrew Curtis to Lead Corporate Strategy and Business Development, Expansion of US Presence

December 2, 2015

Affimed to Present at the Oppenheimer 26th Annual Healthcare Conference –New York

December 1, 2015

Affimed CEO to Present at the Jefferies 2015 Global Healthcare Conference – London

November 11, 2015

Affimed Reports Financial Results for Third Quarter 2015

November 10, 2015

Affimed Presents Data on Potency of NK- and T-cell EGFRvIII TandAbs at SITC

November 6, 2015

Affimed to Present Data on NK- and T-Cell Engagers at ASH

November 5, 2015

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27

Events

All
Scientific
Investors

28Mar

Innate Killer Summit

March 28 - 30, 2023 (San Diego, USA)

WebcastsMore events

Affimed GmbH
Technologiepark
Im Neuenheimer Feld 582
69120 Heidelberg, Germany

Phone: +49 (0)6221-6743-60
Fax: +49 (0)6221 6743-649
email hidden; JavaScript is required

  • Affimed Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Press Release Distribution
    • Corporate Governance
  • Careers
    • Culture

© 2023 Affimed GmbH

  • Data Protection
  • Imprint
  • Contact